Scholarly Index
Anish Thomas
National Cancer Institute; 13,216 total citations; 282 total publications; best world rank #36
National Cancer Institute
13,216Total citations
282Total publications
54H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Lung Cancer Research Studies | Lifetime | 425 | US 190 | 98.43 |
| Cancer therapeutics and mechanisms | Lifetime | 514 | US 268 | 97.36 |
| Occupational and environmental lung diseases | Lifetime | 259 | US 107 | 97.15 |
| Neuroendocrine Tumor Research Advances | Lifetime | 895 | US 343 | 97.34 |
| PARP inhibition in cancer therapy | Lifetime | 315 | US 159 | 96.11 |
| Myasthenia Gravis and Thymoma | Lifetime | 279 | US 91 | 96.43 |
| Pleural and Pulmonary Diseases | Lifetime | 955 | US 355 | 93.67 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 80 | US 25 | 97.58 |
| Cancer therapeutics and mechanisms | 2021-2025 | 36 | US 17 | 97.14 |
| Lung Cancer Research Studies | 2021-2025 | 122 | US 49 | 98.30 |
| Cancer Genomics and Diagnostics | 2021-2025 | 894 | US 380 | 94.84 |
| PARP inhibition in cancer therapy | 2021-2025 | 362 | US 139 | 89.64 |
| DNA Repair Mechanisms | 2021-2025 | 777 | US 312 | 80.99 |